Literature DB >> 28449408

Prediabetes is associated with genetic variations in the gene encoding the Kir6.2 subunit of the pancreatic ATP-sensitive potassium channel (KCNJ11): A case-control study in a Han Chinese youth population.

Min Xu1, Honglin Hu1, Datong Deng1, Mingwei Chen1, Zhenshan Xu2, Youmin Wang1.   

Abstract

BACKGROUND: The E23K variant of the potassium voltage-gated channel subfamily J member 11 (KCNJ11) gene has been reported to be associated with type 2 diabetes (T2D) in many populations. However, little is known about the role of E23K in the development of prediabetes in Chinese youth.
METHODS: To investigate the role of E23K in the development of prediabetes, 279 subjects with prediabetes and 240 normal controls (mean [± SD] age 18.1 ± 3.2 and 17.8 ± 4.3 years, respectively) were recruited to the study. Height, weight, and hip and waist circumferences were measured by trained physicians. Genotyping of KCNJ11 polymorphisms and clinical laboratory tests to determine cholesterol, triglyceride (TG), blood glucose, and insulin levels were performed.
RESULTS: The carrier rate of K23 allele-containing genotypes was higher for prediabetic than control subjects (P = 0.005). Logistic regression analyses revealed that higher body mass index percentiles (P = 0.013), lower insulin levels at 30 min during an oral glucose tolerance test (P = 0.001), a higher ratio of total cholesterol: high-density lipoprotein cholesterol (P = 0.001), and a K allele-containing genotype (P = 0.019) are independent risk factors for prediabetes in Chinese Han youth. Furthermore, K23 allele-containing genotypes were associated with impaired indices of insulin secretion and β-cell function in female youth with prediabetes. These effects were not seen in male youth with prediabetes.
CONCLUSIONS: The results confirm that the common E23K polymorphism of KCNJ11 carries a higher susceptibility to the development of prediabetes in the Chinese Han population. The results suggest that E23K may have a greater effect on the development of T2D in female Chinese youth.
© 2017 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  E23K; gender; polymorphism; potassium voltage-gated channel subfamily J member 11 (KCNJ11); prediabetes; 内向整流钾通道亚家族成员11(KCNJ11); 多态性; 性别; 糖尿病前期

Mesh:

Substances:

Year:  2017        PMID: 28449408     DOI: 10.1111/1753-0407.12565

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  5 in total

1.  Association of KATP Gene Polymorphisms with Dyslipidemia and Ischemic Stroke Risks Among Hypertensive Patients in South China.

Authors:  Cheng Liu; Tianwang Guan; Yanxian Lai; Yan Shen
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

Review 2.  Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels.

Authors:  Paolo Severino; Andrea D'Amato; Lucrezia Netti; Mariateresa Pucci; Marialaura De Marchis; Raffaele Palmirotta; Maurizio Volterrani; Massimo Mancone; Francesco Fedele
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

3.  ATP-sensitive potassium channels gene polymorphism rs1799858 affects the risk of macro-/micro-vascular arteriosclerotic event in patients with increased low-density lipoprotein cholesterol levels.

Authors:  Cheng Liu; Tianwang Guan; Yanxian Lai; Jieming Zhu; Jian Kuang; Yan Shen
Journal:  Lipids Health Dis       Date:  2020-06-23       Impact factor: 3.876

4.  Associations of ATP-Sensitive Potassium Channel's Gene Polymorphisms With Type 2 Diabetes and Related Cardiovascular Phenotypes.

Authors:  Cheng Liu; Yanxian Lai; Tianwang Guan; Junfang Zhan; Jingxian Pei; Daihong Wu; Songsong Ying; Yan Shen
Journal:  Front Cardiovasc Med       Date:  2022-03-23

Review 5.  Functional protection against cardiac diseases depends on ATP-sensitive potassium channels.

Authors:  Peng Ye; Yan-Rong Zhu; Yue Gu; Dai-Min Zhang; Shao-Liang Chen
Journal:  J Cell Mol Med       Date:  2018-09-14       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.